blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3941895

EP3941895 - D-METYROSINE COMPOSITIONS AND METHODS FOR PREPARING SAME [Right-click to bookmark this link]
StatusThe application has been withdrawn
Status updated on  17.03.2023
Database last updated on 11.09.2024
FormerRequest for examination was made
Status updated on  24.12.2021
FormerThe international publication has been made
Status updated on  02.10.2020
Formerunknown
Status updated on  21.04.2020
Most recent event   Tooltip17.03.2023Withdrawal of applicationpublished on 19.04.2023  [2023/16]
Applicant(s)For all designated states
Tyme, Inc.
1 Pluckemin Way
Suite 103
Bedminster, NJ 07921 / US
[2022/04]
Inventor(s)01 / ZUCARO, John
30 W. Kapok Drive
Newark, DE 19702 / US
[N/P]
Former [2022/04]01 / ZUCARO, John
Newark, DE 19702 / US
Representative(s)Høiberg P/S
Adelgade 12
1304 Copenhagen K / DK
[2022/04]
Application number, filing date20718090.218.03.2020
[2022/04]
WO2020US23299
Priority number, dateUS201962822242P22.03.2019         Original published format: US 201962822242 P
[2022/04]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2020197875
Date:01.10.2020
Language:EN
[2020/40]
Type: A1 Application with search report 
No.:EP3941895
Date:26.01.2022
Language:EN
The application published by WIPO in one of the EPO official languages on 01.10.2020 takes the place of the publication of the European patent application.
[2022/04]
Search report(s)International search report - published on:EP01.10.2020
ClassificationIPC:C07C49/255, C07C227/18, C07C237/20, C07C255/43
[2022/04]
CPC:
C07C237/20 (EP,IL,KR); C07C227/18 (EP,IL,KR,US); B01J21/18 (US);
B01J23/44 (US); C07C213/08 (KR); C07C217/56 (KR);
C07C227/42 (KR); C07C229/36 (IL,KR); C07C253/08 (KR);
C07C255/43 (EP,IL,KR); C07C49/255 (EP,IL,KR) (-)
C-Set:
C07C227/18, C07C229/36 (EP)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2022/04]
TitleGerman:D-METYROSIN-ZUSAMMENSETZUNGEN UND VERFAHREN ZUR HERSTELLUNG DAVON[2022/04]
English:D-METYROSINE COMPOSITIONS AND METHODS FOR PREPARING SAME[2022/04]
French:COMPOSITIONS DE D-MÉTYROSINE ET LEURS PROCÉDÉS DE PRÉPARATION[2022/04]
Entry into regional phase29.09.2021National basic fee paid 
29.09.2021Designation fee(s) paid 
29.09.2021Examination fee paid 
Examination procedure29.09.2021Examination requested  [2022/04]
29.09.2021Date on which the examining division has become responsible
06.05.2022Amendment by applicant (claims and/or description)
10.03.2023Application withdrawn by applicant  [2023/16]
Fees paidRenewal fee
10.05.2022Renewal fee patent year 03
Penalty fee
Additional fee for renewal fee
31.03.202203   M06   Fee paid on   10.05.2022
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[X]WO9100270  (RICHTER GEDEON VEGYESZET [HU]) [X] 4 * example 1 *;
 [X]WO2011053835  (ATON PHARMA INC [US], et al) [X] 34,43 * examples *;
 [X]  - OBRECHT D ET AL, "Novel open-chain and cyclic conformationally constrained (R)- and (S)-.alpha.,.alpha.-disubstituted tyrosine analogs", HELVETICA CHIMICA ACTA, (1995), vol. 78, pages 1567 - 1587, XP002008118 [X] 34 * Scheme 1 *

DOI:   http://dx.doi.org/10.1002/hlca.19950780613
 [I]  - IWAO OJIMA ET AL, "New aspects of [beta]-lactam chemistry : [beta]-lactams as chiral bujlding blocks", BULLETIN DE LA SOCIETE CHIMIQUE DE FRANCE, SOCIETE FRANCAISE DE CHIMIE. PARIS, FRANCE, (19870101), no. 5, ISSN 0037-8968, pages 649 - 658, XP009520862 [I] 1-43 * Scheme 5 *
by applicant   - "Prodrugs Revisited: The ''Ad Hoc'' Approach as a Complement to Ligand Design", B. TESTAJ. CALDWELL, Medicinal Research Reviews, John Wiley & Sons, (19960000), vol. 16, pages 233 - 241
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.